Author: Flanz, J.
Paper Title Page
THOBB1
The 3rd Generation of Proton Therapy  
 
  • J. Flanz
    MGH-FHBPTC, Boston, Massachusetts, USA
 
  Funding: National Cancer Institute Federal Share
For 50 years patients have been treated with proton therapy. It began in national laboratories and continued to the next generation of hospital based facilities built by commercial vendors. Proton therapy, while becoming more available still has room for growth. Why hasn't it become more widespread? Issues of cost and optimization of beam parameters have led to questions about the cost effectiveness of this modality and the requirements for more clinical trials. This talk will consider some of the issues that are important for the requirements of a 3rd generation of proton therapy systems.